Long-term follow-up of secondary amyloidosis patients treated with tumor necrosis factor inhibitor therapy: A STROBE-compliant observational study

There are no treatment modalities, which were proven to prevent the deposition of amyloid, proteinuria, and loss of renal function due to amyloidosis. Anti-tumor necrosis factor agents (anti-TNFs) were shown to decrease the production of serum amyloid A protein. We aimed to evaluate the long-term ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Esatoglu, Sinem Nihal, Hatemi, Gulen, Ugurlu, Serdal, Gokturk, Aycan, Tascilar, Koray, Ozdogan, Huri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572020/
https://www.ncbi.nlm.nih.gov/pubmed/28834898
http://dx.doi.org/10.1097/MD.0000000000007859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572020/
https://www.ncbi.nlm.nih.gov/pubmed/28834898
http://dx.doi.org/10.1097/MD.0000000000007859

Ejemplares similares